Business Segments Heron Therapeutics, Inc.
Stocks
HRTX
US4277461020
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4040 USD | -1.08% |
|
-16.98% | -69.12% |
| Jun. 03 | Needham Downgrades Heron Therapeutics to Hold From Buy | MT |
| Jun. 02 | Heron Therapeutics Says US Court Rules 2 Cinvanti Patent Claims 'Invalid' | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Drug Delivery Systems | 86.35M | 108M | 127M | 144M | 155M | |||||
Total Assets | 306M | 251M | 223M | 233M | 256M | |||||
Interest Expense | -2.41M | -2.47M | -3.87M | -6.03M | -9.6M | |||||
CAPEX | -3.02M | -1.82M | -1.54M | -1.71M | -317K | |||||
EBT | -221M | -182M | -111M | -13.58M | -20.2M | |||||
Gross Profit | - | - | 61.94M | 106M | 114M | |||||
D&A | 3.02M | 2.89M | 2.9M | 2.49M | 2.31M | |||||
Operating Income | -218M | -175M | -111M | -11.53M | -2.54M | |||||
Net Income | -221M | -182M | -111M | -13.58M | -20.2M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 86.35M | 108M | 127M | 144M | 155M | |||||
Total Assets | 306M | 251M | 223M | 233M | 256M | |||||
Interest Expense | -2.41M | -2.47M | -3.87M | -6.03M | -9.6M | |||||
D&A | 3.02M | 2.89M | 2.9M | 2.49M | 2.31M | |||||
CAPEX | -3.02M | -1.82M | -1.54M | -1.71M | -317K | |||||
Gross Profit | - | - | 61.94M | 106M | 114M | |||||
Net Income | -221M | -182M | -111M | -13.58M | -20.2M | |||||
EBT | -221M | -182M | -111M | -13.58M | -20.2M | |||||
Operating Income | -218M | -175M | -111M | -11.53M | -2.54M |
- Stock Market
- Stocks
- HRTX Stock
- Financials Heron Therapeutics, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
